Eltek director reports employee stock options

Eltek Ltd director Mordechai Marmorstein has reported existing employee stock option holdings in a Form 3 filing.

Rhea-AI Filing Summary

Eltek Ltd director Mordechai Marmorstein has reported existing employee stock option holdings in a Form 3 filing. He holds options over 10,000 ordinary shares at an exercise price of $5.8900 per share expiring on September 6, 2031, and options over another 10,000 ordinary shares at $8.6700 per share expiring on October 6, 2033. Each option grant vests over four years, with 25% becoming exercisable on the first anniversary of the grant date and 6.25% at the end of each following quarter. The earlier grant was made on September 6, 2021, and the later grant on October 10, 2023.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Marmorstein Mordechai

Role Director

Type	Security	Shares	Price	Value
holding	Employee Stock Option	--	--	--
holding	Employee Stock Option	--	--	--

Holdings After Transaction: Employee Stock Option — 20,000 contracts (Direct)

Footnotes (2)

1. F1. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on September 6, 2021
2. F2. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on October 10, 2023

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider holdings does Eltek (ELTK) director Mordechai Marmorstein report on this Form 3?

Marmorstein reports holding two employee stock option grants. Each covers 10,000 Eltek ordinary shares, one at $5.8900 per share and one at $8.6700 per share, providing potential future equity exposure subject to vesting and exercise.

What are the exercise prices and expirations of the Eltek (ELTK) options reported?

The Form 3 shows employee stock options with exercise prices of $5.8900 and $8.6700 per share. The earlier grant expires on September 6, 2031, and the later grant expires on October 6, 2033, defining the long-term window to exercise.

How do the Eltek (ELTK) director’s stock options vest according to the filing?

Each option grant vests over four years. Twenty-five percent of the options become exercisable on the first anniversary of the grant date, with an additional 6.25% vesting at the end of each subsequent quarter, creating a gradual, time-based vesting schedule.

When were the employee stock options for Eltek (ELTK) director granted?

According to the Form 3, one option grant was made on September 6, 2021 and the other on October 10, 2023. These grant dates start the four-year vesting schedules described in the option agreements.

Does this Eltek (ELTK) Form 3 show the director buying or selling shares?

The Form 3 does not show any share purchases or sales. It reports existing employee stock option holdings and their vesting terms, serving as an initial statement of beneficial ownership rather than recording new market transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 07:51 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Marmorstein Mordechai

(Last) (First) (Middle)

21 WEIZMAN

(Street)

PETACH TIKVA 4955621

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ELTEK LTD [ ELTK ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option	(1)	09/06/2031	Ordinary share	10,000	$5.89	D
Employee Stock Option	(2)	10/06/2033	Ordinary share	10,000	$8.67	D

Explanation of Responses:

1. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on September 6, 2021

2. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on October 10, 2023

	/s/ Marmorstein Mordechai	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)